Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Patient Derived Xenograft (PDX) Models Global Market Report 2025
Download Free Sample Buy Now
Global Patient Derived Xenograft (PDX) Models Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Patient Derived Xenograft (PDX) Models Global Market Report 2025

By Type (Mice Models, Rat Models), By Technique (Heterotopic Implantation, Orthotropic Implantation), By Tumor Type (Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models), By Application (Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research), By End-User (Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Patient Derived Xenograft (PDX) Models Market Overview

• Patient Derived Xenograft (PDX) Models market size has reached to $0.4 billion in 2024

• Expected to grow to $0.81 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%

• Growth Driver: Personalized Medicine's Impact On The PDX Models Market

• Market Trend: Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imaging for Glioblastoma Research

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Patient Derived Xenograft (PDX) Models Market?

Patient-derived xenograft (PDX) models involve transplanting human tumor tissue into immunodeficient animal hosts. They mimic the complexity of human tumors more closely than traditional cell line models. PDX models are crucial for studying tumor biology and testing potential cancer therapies before clinical trials.

The main types in the patient derived xenograft (PDX) models market are mice models and rat models. Mice models refer to laboratory mice genetically modified or bred to study specific biological processes, diseases, or responses to treatments, aiding in biomedical and pharmaceutical research. The various techniques including heterotopic implantation and orthotropic implantation, and several types of tumors including Gastrointestinal Tumor Models, lung tumor models, hematological tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, and others. PDX models find application in preclinical drug development, precision medicine, co-clinical trials, and basic cancer research across academic institutions, research organizations, pharmaceuticals, biotechnology firms, and others.

Patient Derived Xenograft (PDX) Models Market Size and growth rate 2025 to 2029: Graph

What Is The Patient Derived Xenograft (PDX) Models Market Size 2025 And Growth Rate?

The patient derived xenograft (PDX) models market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to research & development investments, regulatory support, partnerships and collaborations, increasing number of contract research organizations (CROs), and rising number of cancer cases.

What Is The Patient Derived Xenograft (PDX) Models Market Growth Forecast?

The patient derived xenograft (PDX) models market size is expected to see rapid growth in the next few years. It will grow to $0.81 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to demand for personalized medicine, rising in demand for humanized PDX models, growing incidence of cancer, focus on precision oncology, and increasing R&D investment for cancer research. Major trends in the forecast period include technological developments, rising demand for humanized PDX models, collaborative research initiatives, growing investments in cancer research, and increasing focus on immuno-oncology.

The forecast of 14.9% growth over the next five years reflects a modest reduction of 1.1% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Patient-Derived Xenograft models sourced from China and Japan, thereby delaying oncology research and elevating cancer center expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Patient Derived Xenograft (PDX) Models Market Segmented?

1) By Type: Mice Models, Rat Models

2) By Technique: Heterotopic Implantation, Orthotropic Implantation

3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models

4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research

5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users

Subsegments:

1) By Mice Models: Immunodeficient Mice Models (Nude Mice, SCID Mice), Humanized Mice Models, Genetically Modified Mice Models

2) By Rat Models: Immunodeficient Rat Models, Humanized Rat Models, Genetically Modified Rat Models

What Is Driving The Patient Derived Xenograft (PDX) Models Market? Personalized Medicine's Impact On The PDX Models Market

The demand for personalized medicine is expected to propel the growth of the patient-derived xenograft (PDX) models market going forward. Personalized medicine involves tailoring medical treatment to each patient's specific characteristics, considering factors such as genetics, environment, and lifestyle. The demand for personalized medicine is increasing due to advancements in genomic research, which enable tailored treatments based on individual genetic profiles, leading to more effective and targeted healthcare outcomes. Patient-derived xenograft (PDX) models aid personalized medicine by allowing the testing of individual patient tumors to predict treatment responses and tailor therapies accordingly. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit umbrella organization, in 2023, the FDA approved 16 new personalized treatments for rare diseases, a significant increase from six approvals in 2022. Therefore, the demand for personalized medicine drives the patient-derived xenograft (PDX) models market growth.

Who Are The Major Players In The Global Patient Derived Xenograft (PDX) Models Market?

Major companies operating in the patient derived xenograft (PDX) models market are Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc, Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech, Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere, Hera BioLabs, InnoSer, Pharmatest Services Ltd., IVRS AB, Altogen Inc

What Are The Key Trends Of The Global Patient Derived Xenograft (PDX) Models Market? Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imaging for Glioblastoma Research

Major companies operating in the patient-derived xenograft (PDX) models market are developing innovative models with in vivo bioluminescence imaging capabilities to enable real-time monitoring of tumor growth. In vivo bioluminescence imaging helps PDX models by enabling non-invasive real-time monitoring of tumor metastasis and treatment responses, enhancing the effectiveness of preclinical research in drug development. For instance, in March 2024, InVitro Research Solutions Private Limited, an India-based Contract Research Organization (CRO), launched an innovative orthotopic model of human glioblastoma in NSG-SGM3 mice by using patient-derived xenografts (PDX) and in vivo bioluminescence imaging. This model aims to enable personalized treatment of glioblastoma, the most common and aggressive type of brain cancer. These models are critical for understanding glioblastoma biology and evaluating new targeted therapies and immunotherapies to improve outcomes.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Patient Derived Xenograft (PDX) Models Market? Merck Acquired Modifi Biosciences To Enhance Oncology Portfolio With DNA Repair-Targeting Cancer Therapies

In October 2024, Merck & Co., Inc., a US-based pharmaceutical company, acquired Modifi Biosciences, Inc., for $1.3 billion. This acquisition aligns with Merck's strategy to strengthen its oncology portfolio by integrating Modifi's innovative research, including preclinical drug candidates and patient-derived xenograft model data, to advance therapies for cancers with DNA repair deficiencies. Modifi Biosciences, Inc., a US-based biotechnology firm specializing in cancer therapeutics through direct DNA modification.

What Is The Regional Outlook For The Global Patient Derived Xenograft (PDX) Models Market?

North America was the largest region in the patient derived xenograft (PDX) models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Patient Derived Xenograft (PDX) Models Market?

The patient derived xenograft (PDX) models market includes revenues earned by entities by providing services such as evaluating drug efficacy, studying tumor biology, and predicting patient-specific treatment responses in preclinical cancer research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Patient Derived Xenograft (PDX) Models Industry?

The patient derived xenograft (pdx) models market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient derived xenograft (pdx) models industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Patient Derived Xenograft (PDX) Models Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.47 billion
Revenue Forecast In 2034 $0.81 billion
Growth Rate CAGR of 14.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Mice Models, Rat Models
2) By Technique: Heterotopic Implantation, Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models
4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research
5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users Subsegments: 1) By Mice Models: Immunodeficient Mice Models (Nude Mice, SCID Mice), Humanized Mice Models, Genetically Modified Mice Models
2) By Rat Models: Immunodeficient Rat Models, Humanized Rat Models, Genetically Modified Rat Models
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc, Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech, Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere, Hera BioLabs, InnoSer , Pharmatest Services Ltd., IVRS AB, Altogen Inc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Patient Derived Xenograft (PDX) Models Market Characteristics

3. Patient Derived Xenograft (PDX) Models Market Trends And Strategies

4. Patient Derived Xenograft (PDX) Models Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Patient Derived Xenograft (PDX) Models Growth Analysis And Strategic Analysis Framework

5.1. Global Patient Derived Xenograft (PDX) Models PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Patient Derived Xenograft (PDX) Models Market Growth Rate Analysis

5.4. Global Patient Derived Xenograft (PDX) Models Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Patient Derived Xenograft (PDX) Models Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Patient Derived Xenograft (PDX) Models Total Addressable Market (TAM)

6. Patient Derived Xenograft (PDX) Models Market Segmentation

6.1. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mice Models

Rat Models

6.2. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Heterotopic Implantation

Orthotropic Implantation

6.3. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gastrointestinal Tumor Models

Lung Tumor Models

Hematological Tumor Models

Gynecological Tumor Models

Respiratory Tumor Models

Urological Tumor Models

Other Tumor Models

6.4. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical Drug Development

Precision Medicine

Co-Clinical Trials

Basic Cancer Research

6.5. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Academic And Research Organizations

Contract Research Organizations

Pharmaceutical And Biotechnological Companies

Other End-Users

6.6. Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Mice Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunodeficient Mice Models (Nude Mice, SCID Mice)

Humanized Mice Models

Genetically Modified Mice Models

6.7. Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Rat Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunodeficient Rat Models

Humanized Rat Models

Genetically Modified Rat Models

7. Patient Derived Xenograft (PDX) Models Market Regional And Country Analysis

7.1. Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Derived Xenograft (PDX) Models Market

8.1. Asia-Pacific Patient Derived Xenograft (PDX) Models Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Derived Xenograft (PDX) Models Market

9.1. China Patient Derived Xenograft (PDX) Models Market Overview

9.2. China Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Derived Xenograft (PDX) Models Market

10.1. India Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Derived Xenograft (PDX) Models Market

11.1. Japan Patient Derived Xenograft (PDX) Models Market Overview

11.2. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Derived Xenograft (PDX) Models Market

12.1. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Derived Xenograft (PDX) Models Market

13.1. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Derived Xenograft (PDX) Models Market

14.1. South Korea Patient Derived Xenograft (PDX) Models Market Overview

14.2. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Derived Xenograft (PDX) Models Market

15.1. Western Europe Patient Derived Xenograft (PDX) Models Market Overview

15.2. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Derived Xenograft (PDX) Models Market

16.1. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Derived Xenograft (PDX) Models Market

17.1. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Derived Xenograft (PDX) Models Market

18.1. France Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Derived Xenograft (PDX) Models Market

19.1. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Derived Xenograft (PDX) Models Market

20.1. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Derived Xenograft (PDX) Models Market

21.1. Eastern Europe Patient Derived Xenograft (PDX) Models Market Overview

21.2. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Derived Xenograft (PDX) Models Market

22.1. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Derived Xenograft (PDX) Models Market

23.1. North America Patient Derived Xenograft (PDX) Models Market Overview

23.2. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Derived Xenograft (PDX) Models Market

24.1. USA Patient Derived Xenograft (PDX) Models Market Overview

24.2. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Derived Xenograft (PDX) Models Market

25.1. Canada Patient Derived Xenograft (PDX) Models Market Overview

25.2. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Derived Xenograft (PDX) Models Market

26.1. South America Patient Derived Xenograft (PDX) Models Market Overview

26.2. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Derived Xenograft (PDX) Models Market

27.1. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Derived Xenograft (PDX) Models Market

28.1. Middle East Patient Derived Xenograft (PDX) Models Market Overview

28.2. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Derived Xenograft (PDX) Models Market

29.1. Africa Patient Derived Xenograft (PDX) Models Market Overview

29.2. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Derived Xenograft (PDX) Models Market Competitive Landscape And Company Profiles

30.1. Patient Derived Xenograft (PDX) Models Market Competitive Landscape

30.2. Patient Derived Xenograft (PDX) Models Market Company Profiles

30.2.1. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

30.2.2. WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. The Jackson Laboratory Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Inotiv Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Patient Derived Xenograft (PDX) Models Market Other Major And Innovative Companies

31.1. Biocytogen Pharmaceuticals Co. Ltd.

31.2. Taconic Biosciences Inc.

31.3. BioDuro-Sundia Inc.

31.4. Horizon Discovery Ltd.

31.5. Crown Bioscience Inc.

31.6. Champions Oncology Inc.

31.7. Oncodesign Services S.A.

31.8. Genesis Biotechnology Group LLC.

31.9. Creative Animodel

31.10. Abnova Corp.

31.11. Certis Oncology Solutions Inc.

31.12. Xentech

31.13. Aragen Bioscience Inc.

31.14. EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH.

31.15. Urosphere

32. Global Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Derived Xenograft (PDX) Models Market

34. Recent Developments In The Patient Derived Xenograft (PDX) Models Market

35. Patient Derived Xenograft (PDX) Models Market High Potential Countries, Segments and Strategies

35.1 Patient Derived Xenograft (PDX) Models Market In 2029 - Countries Offering Most New Opportunities

35.2 Patient Derived Xenograft (PDX) Models Market In 2029 - Segments Offering Most New Opportunities

35.3 Patient Derived Xenograft (PDX) Models Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Mice Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Rat Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Laboratory Corporation of America Holdings Financial Performance
  • Table 79: WuXi AppTec Co. Ltd. Financial Performance
  • Table 80: Charles River Laboratories International Inc. Financial Performance
  • Table 81: The Jackson Laboratory Financial Performance
  • Table 82: Inotiv Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Mice Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Patient Derived Xenograft (PDX) Models Market, Sub-Segmentation Of Rat Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Laboratory Corporation of America Holdings Financial Performance
  • Figure 79: WuXi AppTec Co. Ltd. Financial Performance
  • Figure 80: Charles River Laboratories International Inc. Financial Performance
  • Figure 81: The Jackson Laboratory Financial Performance
  • Figure 82: Inotiv Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Patient Derived Xenograft (PDX) Models Global Market Report 2025 – By Type (Mice Models, Rat Models), By Technique (Heterotopic Implantation, Orthotropic Implantation), By Tumor Type (Gastrointestinal Tumor Models, Lung ...

View Report

Xenotransplantation Global Market Report 2025 – By Products (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products), By Treatment (Analgesic, Immunosuppressant, Other Treatments), By Applications (Heart, ...

View Report

Xerostomia Therapeutics Global Market Report 2025 – By Type (Artificial Saliva Or Saliva Substitutes, Salivary Stimulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmac...

View Report

Patient Simulators Global Market Report 2025 – By Type (Childbirth Simulator, Adult Patient Simulator, Infant Simulator, Other Types), By Intensity (High-Fidelity Simulator, Medium-Fidelity Simulator, Low-Fidelity Simula...

View Report

Anatomical Models Global Market Report 2025 – By Type (Brain Model, Torso Model, Organ Model, Nervous System Model, Skeletal System Model, Hand Model, Eye Model, Tooth Model, Digestive System Model), By Printing Technolo...

View Report

Xylene Global Market Report 2025 – By Type (Ortho-Xylene, Meta-Xylene, Para-Xylene, Mixed Xylene), By Application (Automotive, Textile, Chemical, Oil and Gas, Leather, Paints and Coatings, Rubber), By End User (Plastics ...

View Report

Medical X-Ray Equipment And Imaging Software Global Market Report 2025 – By Type (Equipment, Software), By Technology (Radiography Or Mammography, Computed Tomography, Fluoroscopy Or Angiography), By Image Type (2-Dimens...

View Report

Anti-Neoplastic Agents Global Market Report 2025 – By Type (Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous), By Disease Type (Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Can...

View Report

Frequently Asked Questions

Patient-derived xenograft (PDX) models involve transplanting human tumor tissue into immunodeficient animal hosts. They mimic the complexity of human tumors more closely than traditional cell line models. PDX models are crucial for studying tumor biology and testing potential cancer therapies before clinical trials. For further insights on this market, request a sample here

The market major growth driver - Personalized Medicine's Impact On The PDX Models Market. For further insights on this market, request a sample here

The patient derived xenograft (pdx) models market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to research & development investments, regulatory support, partnerships and collaborations, increasing number of contract research organizations (CROs), and rising number of cancer cases. The patient derived xenograft (pdx) models market size is expected to see rapid growth in the next few years. It will grow to " $0.81 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to demand for personalized medicine, rising in demand for humanized PDX models, growing incidence of cancer, focus on precision oncology, and increasing R&D investment for cancer research. Major trends in the forecast period include technological developments, rising demand for humanized PDX models, collaborative research initiatives, growing investments in cancer research, and increasing focus on immuno-oncology. For further insights on this market, request a sample here

The patient derived xenograft (pdx) modelsmarket covered in this report is segmented –
1) By Type: Mice Models; Rat Models
2) By Technique: Heterotopic Implantation; Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models; Lung Tumor Models; Hematological Tumor Models; Gynecological Tumor Models; Respiratory Tumor Models; Urological Tumor Models; Other Tumor Models
4) By Application: Preclinical Drug Development; Precision Medicine; Co-Clinical Trials; Basic Cancer Research
5) By End-User: Academic And Research Organizations; Contract Research Organizations; Pharmaceutical And Biotechnological Companies; Other End-Users Subsegments:
1) By Mice Models: Immunodeficient Mice Models (Nude Mice, SCID Mice); Humanized Mice Models; Genetically Modified Mice Models
2) By Rat Models: Immunodeficient Rat Models; Humanized Rat Models; Genetically Modified Rat Models For further insights on this market, request a sample here

North America was the largest region in the patient derived xenograft (PDX) models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient derived xenograft (PDX) models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the patient derived xenograft (PDX) models market are Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc, Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech, Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere, Hera BioLabs, InnoSer, Pharmatest Services Ltd., IVRS AB, Altogen Inc. For further insights on this market, request a sample here.

Major trends in this market include Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imaging for Glioblastoma Research. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Patient Derived Xenograft (PDX) Models Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon